Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-PIMPS: Trigger Point Injection for Myofascial Low Back Pain
NCT04704297Phase 4Recruiting
- Sponsor
- Madigan Army Medical Center
- Start
- Dec 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in myofascial pain syndrome (MPS), sponsored by Madigan Army Medical Center. Started Dec 2020; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT04704297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04704297.